Literature DB >> 1335482

Replication of varicella zoster virus in primary human keratinocytes.

C J Sexton1, H A Navsaria, I M Leigh, K Powell.   

Abstract

The ability of varicella zoster virus (VZV) to infect and replicate in human keratinocytes in culture was examined. Primary human keratinocytes derived from the abdomen, breast, and foreskin were plated as monolayers and infected by co-cultivation with VZV infected fibroblasts (MRC-5 cells). Replication and spread of the virus was assayed by plaque assay and immunofluorescence of infected cells using a VZV specific monoclonal antibody. Although all three types of keratinocytes tested were capable of supporting productive VZV infection, the keratinocytes showed a 1.5 to 2 log reduction in virus yield as compared to infection of monolayer cultures of MRC-5 cells. Results from immunofluorescence studies and plaque assays indicate a slower rate of cell-to-cell spread of the virus. Testing of an anti-VZV compound in this novel assay system demonstrated an interesting sensitivity compared to that observed in conventional assay systems.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335482     DOI: 10.1002/jmv.1890380406

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  4 in total

1.  Organotypic epithelial raft cultures as a model for evaluating compounds against alphaherpesviruses.

Authors:  Graciela Andrei; Joost van den Oord; Pierre Fiten; Ghislain Opdenakker; Chris De Wolf-Peeters; Erik De Clercq; Robert Snoeck
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

2.  β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.

Authors:  Chandrav De; Dongmei Liu; Bo Zheng; Uma S Singh; Satish Chavre; Catherine White; Robert D Arnold; Fred K Hagen; Chung K Chu; Jennifer F Moffat
Journal:  Antiviral Res       Date:  2014-07-19       Impact factor: 5.970

3.  Development of a skin- and neuro-attenuated live vaccine for varicella.

Authors:  Wei Wang; Dequan Pan; Wenkun Fu; Xiangzhong Ye; Jinle Han; Lianwei Yang; Jizong Jia; Jian Liu; Rui Zhu; Yali Zhang; Che Liu; Jianghui Ye; Anca Selariu; Yuqiong Que; Qinjian Zhao; Ting Wu; Yimin Li; Jun Zhang; Tong Cheng; Hua Zhu; Ningshao Xia
Journal:  Nat Commun       Date:  2022-02-11       Impact factor: 17.694

4.  RNA-seq analysis of host and viral gene expression highlights interaction between varicella zoster virus and keratinocyte differentiation.

Authors:  Meleri Jones; Inga R Dry; Dan Frampton; Manuraj Singh; Ravinder K Kanda; Michael B Yee; Paul Kellam; Michael Hollinshead; Paul R Kinchington; Edel A O'Toole; Judith Breuer
Journal:  PLoS Pathog       Date:  2014-01-30       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.